OTC Markets EXMKT - Delayed Quote USD
Talis Biomedical Corporation (TLIS)
1.6000
0.0000
(0.00%)
At close: April 25 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-40,258
-53,240
-100,136
-171,384
-87,024
Investing Cash Flow
137
-486
-1,615
-2,866
-8,201
Financing Cash Flow
2
33
406
234,429
246,754
End Cash Position
60,633
78,274
131,967
233,312
173,133
Capital Expenditure
--
-486
-1,615
-2,866
-8,201
Issuance of Capital Stock
--
--
--
232,546
248,189
Free Cash Flow
-40,235
-53,726
-101,751
-174,250
-95,225
12/31/2020 - 2/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CUTRQ Cutera, Inc.
0.0100
+26.58%
TLSI TriSalus Life Sciences, Inc.
5.73
+1.42%
SIBN SI-BONE, Inc.
14.41
+0.14%
XTNT Xtant Medical Holdings, Inc.
0.5100
+6.25%
SGHT Sight Sciences, Inc.
3.2200
-2.13%
HSDT Helius Medical Technologies, Inc.
0.2920
-2.24%
BVS Bioventus Inc.
7.65
-1.03%
LAB Standard BioTools Inc.
1.1600
-5.69%
VTAK Catheter Precision, Inc.
0.2898
+1.76%
BBNX Beta Bionics, Inc.
10.96
-0.90%